High-resolution Infrared Spectroscopy of the v23 and v22 Vibrational Bands of Methyl Vinyl Ketone

The high-resolution Infrared spectrum of methyl vinyl ketone (C4H6O) has been acquired in the region containing the v22 and v23 bands near 987 cm-1 and 1001cm-1, respectively, using a quantum cascade laser-based spectrometer. All acquired spectra underwent frequency calibrations that will prove useful during future atmospheric measurements of methyl vinyl ketone. Anharmonic calculations were performed at the MP2/ccp-pVTZ level of theory to obtain the vibrational frequencies and the excited state rotational constants of cis-methyl vinyl ketone. These calculations supported the assignment of the Q-branch features at 1001.031 and 987.592 cm-1 to the v22 and v23 fundamental vibrations of the molecule. Additionally, the Q-branch feature at 998.98 cm-1 was assigned as a hot band of the v23 mode arising from the v26 mode. The calculated rotational constants were used as starting points to begin preliminary spectral simulations of the v22 and v23 bands

Height, weight and limb bones length of the embryos of pregnant mice injected by sodium valproate

Background and aim: Valproic acid (and its salt, sodium valproate) is one of the drugs that has been widely used for treatment of epileptic patients during the recent decades. The aim of this study was to find the effects of the drug on the morphological characteristics (such as height and weight) and limb bones of mouse embryo. Methods: Case group consisted of 8 pregnant mice that on the ninth day of their gestation, sodium valproate (200 mg/kg) was intraperitonealy injected at three consecutive times (at 0, 6, 12 hours). Seven pregnant mice were injected by distilled water as the control group. On the 18th day of gestation, pregnant mice of both groups were killed by cervical dislocation and their embryos were removed. The embryos height and weight were measured. Then some of embryos were used for Alizarin red & Alciane blue staining. By this method of staining soft tissues would become clear, cartilages become blue and bones turn to red. In stained embryos, the lengths of limb bones were measured. Results: Height and weight of the case group was significantly less than those of the control group. Also, the length of femoral, tibial, fibular, humeral, radial and ulnar bones was significantly less in the case group. Conclusion: Administration of sodium valproate during pregnancy decreases the height and weight of embryos and could cause delay in growth of the limb bones, therefore should not be used during pregnancy.

The effects of lead on motility, viability and DNA denaturation of cauda epididymal spermatozoa of mouse

زمینه و هدف: سرب یکی از آلوده کننده های محیطی است. در این مطالعه اثرات سرب بر تحرک، زنده ماندن و دناتوره شدن DNA اسپرم موش مورد بررسی قرار گرفت. هدف ما بررسی اثرات سرب بر این فاکتورها و نیز قابل بازگشت بودن یا نبودن این اثرات بود. روش بررسی: در این مطالعه تجربی 24 موش نر به عنوان گروه آزمایش و 24 موش نیز، گروه کنترل در نظرگرفته شدند. به موش های گروه آزمایش 200 میلی گرم بر کیلوگرم محلول استات سرب و به موش های گروه کنترل تنها آب مقطر به صورت داخل صفاقی تزریق گردید. پس از آن هر کدام از گروه ها به سه زیر گروه مساوی تقسیم شدند و موش های هر زیر گروه در هفته های اول، دوم و سوم پس از تزریق کشته و اپیدیدیم آن ها برداشته شد. در تمامی گروه ها درصد اسپرم های متحرک، درصد اسپرم های زنده و میزان دناتوره شدن اسپرم های ناحیه دم اپیدیدیم اندازه گیری شد. داده ها به کمک آزمون های آماری من ویتنی و کروسکال والیس تجزیه و تحلیل شد. یافته ها: سرب سبب کاهش میزان تحرک و زنده ماندن اسپرم ها در هفته اول پس از تزریق شد (05/0

The efficacy of resveratrol in controlling hypertension: study protocol for a randomized, crossover, double-blinded, placebo-controlled trial

Background: Hypertension is a global health concern for which novel treatment strategies are necessary. The aim of this study is to evaluate the efficacy of resveratrol (trans-3, 5, 4′-trihydroxystilbene, a polyphenol present in grapes) in controlling blood pressure in participants diagnosed with prehypertension and stage 1 hypertension. Methods/design: In a randomized, crossover, double-blinded, placebo-controlled study, 50 participants with prehypertension (diastolic blood pressure and systolic blood pressure, 80–89 mmHg and 120–139 mmHg, respectively) and 50 participants with stage 1 hypertension (diastolic and systolic, 90–99 mmHg and 140–159 mmHg, respectively) will be assigned to receive resveratrol (99 % pure, from Biotivia Longevity Bioceuticals LLC Company, USA, in 500 mg capsules, twice daily for 4 weeks, orally) or placebo (500 mg neutral microcellulose capsules, twice daily for 4 weeks) in a 2 × 2 crossover design (4 weeks treatment—4 weeks washout—4 weeks treatment). The blood pressure of each participant will be recorded (a mean of two times within a 15-minute interval) every week during the study. The participants in the prehypertensive group will not receive any medication, while those in the stage 1 hypertensive group will continue to receive their routine medications during the study. Blood samples will be taken from all groups and examined for various biochemical parameters. Discussion: This trial will help to establish whether resveratrol is an effective antihypertensive agent in prehypertensive and stage 1-hypertensive patients. The trial outcome will provide novel insight into the clinical efficacy of resveratrol and provide valuable information for conducting future clinical studies with resveratrol. Trial registration: Iranian Registry of Clinical Trials, IRCT201407078129N7. Registered on 15 August 2014. Keywords: Resveratrol, Hypertension, Blood pressure, Polyphen

Coadministration of calcium chloride with lead acetate can improve motility of cauda epididymal spermatozoa in Swiss white mice

Background: Lead is an industrial heavy metal that can decrease sperm motility. Objective: The aim was to investigate the protective effects of calcium against lead on motility of spermatozoa. Materials and Methods: In total 40 adult male Swiss white mice were randomly divided into 5 groups (control, lead of 1st wk, lead of 2nd wk, lead/calcium of 1stwk and lead/calcium of 2nd wk). The lead groups of mice were injected by a single dose of lead acetate (200 mg/kg) intraperitoneally. Lead/calcium groups of mice were injected by a single same dose of lead acetate along with three doses of 80 mg/kg calcium chloride. The control group of mice was injected only with same volume of distilled water through the same route. Mice of 1st and 2nd wk groups were sacrificed through cervical dislocation one and two weeks after injections respectively. Results: Mean of the progressive motile spermatozoa of cauda epididymis in lead/calcium group of the first week was higher than the lead group of the first week and this difference was significant. There was not any significant difference among weight of testes and epididymides of all groups. Conclusion: It can be concluded that calcium can decrease the effects of lead on sperm motility. © 2016, Research and Clinical Center for Infertitlity. All rights reserved

Plasma malondialdehyde, bilirubin, homocysteine and total antioxidant capacity in patients with angiographically defined coronary artery disease

Oxidative stress has been implicated in coronary artery disease (CAD). Malondialdehyde (MDA) is lipid peroxidation end product. Bilirubin may act as an antioxidant that suppresses lipid oxidation. The role of MDA and antioxidant capacity and their inter-relationship in patients with and without CAD was investigated. Thirty-eight consecutive patients with angiographically diagnosed CAD were compared with 60 age, and sex-matched controls. The controls had completely normal coronary arteries in angiograms. Plasma MDA, serum bilirubin, total homocysteine and total antioxidant capacity (TAC) levels were measured. Risk factors of CAD were determined for all subjects using National Cholesterol Education Program (NCEP)-Adult Treatment Panel (ATP)-III criteria. Serum MDA and total homocysteine concentration were significantly higher, but TAC, total bilirubin and direct bilirubin levels were lower in CAD patients when compared to the controls. Age, and sex-adjusted plasma MDA levels had negative correlations with TAC (r = -0.30, p = 0.001) and total bilirubin (r = -0.30, p = 0.002) concentrations. In multivariate analysis by the multiple logistic regression method, serum MDA was significantly associated with CAD (OR = 1.15, 95% CI, 1.25 to 1.82; p < 0.0001)) after adjustment for lipid status parameters and traditional risk factors in this study population. Increased serum MDA concentration, as a biomarker of lipid peroxidation, low serum bilirubin and antioxidant capacity were observed in patients with angiographically defined CAD. The significant inverse correlation of the serum bilirubin and MDA levels demands further in-depth investigations to clarify the association between them in the development of CAD

Complete improvement in a patient with multiple irreversible defects of the left ventricle on 99m technetium-sestamibi SPECT after percutaneous coronary intervention.

99mTc-sestamibi has been investigated as a potential viability marker; initial studies have shown good concordance between 201Tl and 99mTc-sestamibi activities in both viable and nonviable myocardium. However, assessment of myocardial viability by 99mTc-sestamibi remains controversial for tissue recovery after revascularization. Here, we present a patient with several regions of severely diminished and irreversible (defect persisting in both early and delay images of each set scanning) defects on initial scan which were dissolved completely on the follow up scan after an intervention. In a 75 year-old Asian woman with acute myocardial infarction who received thrombolytic therapy and subjected to percutaneous coronary angiography (PCI) on day 28 after acute myocardial infarction(MI), resting 99mTc-sestamibi SPECT was applied on day 4 (initial scan) and 138 (follow up scan) after acute MI at 30 and 180 min after injection of tracer (740 MBq); Two-dimensional echocardiography was carried out at the same time. On the initial image set, there was irreversible defects in the apex, anteroapical, inferoapical, anteroseptal, septal and also anterior walls, while the follow up image was normal in all regions.The angiography intervention showed just significant stenosis on left anterior descending (LAD) vessel (95). This may highlight the failure of 99mTc-sestamibi as a marker of myocardial viability and also mandate further validating of the procedure with follow up scan or other modalities for myocardial viability investigation

Radiolabeled neurogenesis marker imaging: A revolution in the neurological diseases management?

A reduced rate of neurogenesis occurs in the adult brain of patients with neurological diseases, with the rate of new neuron proliferation not sufficient to replace neuron loss. Neurogenesis can be induced by several factors, including basic fibroblast growth factor, epidermal growth factor, and brain-derived neurotrophic factor. Neurogenesis determination is a valuable parameter for determining disease progression and monitoring various treatments. Currently, neurogenesis detection is possible by invasive methods, such as bromodeoxyuridine (BrdU) cell labeling and immunohistological analysis of immature neuron markers. However, these are not compatible with alive model examination. Neurogenesis detection by noninvasive methods, such as radiolabeling of specific antibodies and scintigraphy imaging, could shed light on immature neuronal markers. We propose that brain scintigraphy after radiolabeling of a specific antibody of an immature neuronal marker is a useful new modality for neurogenesis detection and that it would aid the management of neurological diseases